Department of Biomedical Engineering
Jonathan F. Lovell has not added Biography.
If you are Jonathan F. Lovell and would like to personalize this page please email our Author Liaison for assistance.
Bcl-XL inhibits membrane permeabilization by competing with Bax.
PLoS biology Jun, 2008 | Pubmed ID: 18547146
A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Jul, 2008 | Pubmed ID: 18597024
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.
Cell Dec, 2008 | Pubmed ID: 19062087
FRET quenching of photosensitizer singlet oxygen generation.
The journal of physical chemistry. B Mar, 2009 | Pubmed ID: 19708269
Biomimetic nanocarrier for direct cytosolic drug delivery.
Angewandte Chemie (International ed. in English) , 2009 | Pubmed ID: 19876988
HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
Small (Weinheim an der Bergstrasse, Germany) Feb, 2010 | Pubmed ID: 19957284
Activatable photosensitizers for imaging and therapy.
Chemical reviews May, 2010 | Pubmed ID: 20104890
Facile synthesis of advanced photodynamic molecular beacon architectures.
Bioconjugate chemistry Jun, 2010 | Pubmed ID: 20509598
Programmed nanoparticle aggregation using molecular beacons.
Angewandte Chemie (International ed. in English) Oct, 2010 | Pubmed ID: 20853381
Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology May, 2011 | Pubmed ID: 21344108
Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles.
Small (Weinheim an der Bergstrasse, Germany) Mar, 2011 | Pubmed ID: 21370456
Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.
Nature materials Apr, 2011 | Pubmed ID: 21423187
Lipoprotein-inspired nanoparticles for cancer theranostics.
Accounts of chemical research Oct, 2011 | Pubmed ID: 21557543
Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection.
Biomacromolecules Sep, 2011 | Pubmed ID: 21777008
Biodegradable star polymers shine for cancer drug delivery.
Nanomedicine (London, England) Sep, 2011 | Pubmed ID: 21929456
Porphyrin FRET acceptors for apoptosis induction and monitoring.
Journal of the American Chemical Society Nov, 2011 | Pubmed ID: 22026412
Downsizing nanoparticles for better tumor penetration and accumulation.
Nanomedicine (London, England) Sep, 2011 | Pubmed ID: 22029058
Bursting the bubble: microbubble–nanoparticle composites for ultrasound-mediated drug delivery.
Nanomedicine (London, England) Sep, 2011 | Pubmed ID: 22029059
A challenger appears: a copper nanocolloid for MR detection of atherosclerotic plaques.
Nanomedicine (London, England) Sep, 2011 | Pubmed ID: 22029060
A new endogenous and immunologically inert siRNA delivery vehicle for targeting the brain.
Nanomedicine (London, England) Sep, 2011 | Pubmed ID: 22029061
Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
Bioconjugate chemistry Jan, 2012 | Pubmed ID: 22142191
Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles.
Angewandte Chemie (International ed. in English) Mar, 2012 | Pubmed ID: 22267090
Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties.
Journal of the American Chemical Society Oct, 2012 | Pubmed ID: 22827774
Porphyrins and phthalocyanines for theranostics.
Theranostics , 2012 | Pubmed ID: 23082094
Porphyrins as theranostic agents from prehistoric to modern times.
Theranostics , 2012 | Pubmed ID: 23082102
Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly.
ACS nano Mar, 2013 | Pubmed ID: 23394589
Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications.
ACS nano Apr, 2013 | Pubmed ID: 23464857
The use of nanoparticulate delivery systems in metronomic chemotherapy.
Biomaterials May, 2013 | Pubmed ID: 23465835
1Department of Pharmaceutical Sciences, University of Toronto,
2The Institute of Biomaterials and Biomedical Engineering, University of Toronto,
3Ontario Cancer Institute, Campbell Family Institute For Cancer Research and Techna Institute,
4Department of Biomedical Engineering, University at Buffalo, The State University of New York
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved